Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the PD-1/PD-L1 Immunotherapy industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Innovent Biologics Inc
BeiGene Ltd
Pfizer Inc
Merck & Co Inc
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Novartis AG
Eli Lilly & Company
Sanofi SA
GlaxoSmithKline plc
Bristol-Myers Squibb Company
F Hoffmann-La Roche Ltd
Regeneron Pharmaceuticals Inc
AstraZeneca Plc
Jiangsu HengRui Medicine Co Ltd
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
PD-1 Inhibitors
PD-L1 Inhibitors
Application:
Non-Small Cell Lung Cancer
Esophageal Cancer
Urothelial Carcinoma
Hepatocellular Carcinoma
Small Cell Lung Cancer
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 PD-1/PD-L1 Immunotherapy Industry Overview
-
1.1.1 PD-1/PD-L1 Immunotherapy Market Scope and Market Segments
-
1.1.2 PD-1/PD-L1 Immunotherapy Industry Characteristics
-
1.1.3 Global and China PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China PD-1/PD-L1 Immunotherapy Production Value and Growth Rate (2017-2028)
-
1.2 Global PD-1/PD-L1 Immunotherapy Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 PD-1 Inhibitors
-
1.2.2 PD-L1 Inhibitors
-
1.3 Global PD-1/PD-L1 Immunotherapy Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Non-Small Cell Lung Cancer
-
1.3.2 Esophageal Cancer
-
1.3.3 Urothelial Carcinoma
-
1.3.4 Hepatocellular Carcinoma
-
1.3.5 Small Cell Lung Cancer
-
1.3.6 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America PD-1/PD-L1 Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe PD-1/PD-L1 Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC PD-1/PD-L1 Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa PD-1/PD-L1 Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global PD-1/PD-L1 Immunotherapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global PD-1/PD-L1 Immunotherapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China PD-1/PD-L1 Immunotherapy Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China PD-1/PD-L1 Immunotherapy Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global PD-1/PD-L1 Immunotherapy Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 PD-1/PD-L1 Immunotherapy Industry Porter's Five Forces Model Analysis
-
2.2.3 PD-1/PD-L1 Immunotherapy Industry PEST Analysis
-
2.3 PD-1/PD-L1 Immunotherapy Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 PD-1/PD-L1 Immunotherapy Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on PD-1/PD-L1 Immunotherapy Industry
Chapter 3 Global and China PD-1/PD-L1 Immunotherapy Market, by Manufacturer
-
3.1 Global and China PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China PD-1/PD-L1 Immunotherapy Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China PD-1/PD-L1 Immunotherapy Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China PD-1/PD-L1 Immunotherapy Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China PD-1/PD-L1 Immunotherapy Market Top 3 Players
Chapter 4 Global and China PD-1/PD-L1 Immunotherapy Market, by Type (2017-2028)
-
4.1 PD-1/PD-L1 Immunotherapy Market Trend, by Type
-
4.2 Global PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global PD-1/PD-L1 Immunotherapy Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global PD-1/PD-L1 Immunotherapy Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global PD-1/PD-L1 Immunotherapy Price Trend, by Type (2017-2028)
-
4.3 China PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China PD-1/PD-L1 Immunotherapy Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China PD-1/PD-L1 Immunotherapy Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China PD-1/PD-L1 Immunotherapy Price Trend, by Type (2017-2028)
Chapter 5 Global and China PD-1/PD-L1 Immunotherapy Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global PD-1/PD-L1 Immunotherapy Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global PD-1/PD-L1 Immunotherapy Sales Value and Market Share, by Application (2017-2028)
-
5.3 China PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China PD-1/PD-L1 Immunotherapy Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China PD-1/PD-L1 Immunotherapy Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global PD-1/PD-L1 Immunotherapy Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China PD-1/PD-L1 Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
6.2 North America PD-1/PD-L1 Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe PD-1/PD-L1 Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC PD-1/PD-L1 Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa PD-1/PD-L1 Immunotherapy Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America PD-1/PD-L1 Immunotherapy Market Analysis
-
7.1 North America PD-1/PD-L1 Immunotherapy Market, by Type
-
7.2 North America PD-1/PD-L1 Immunotherapy Market, by Application
-
7.3 North America PD-1/PD-L1 Immunotherapy Market Analysis and Forecast, by Country
-
7.3.1 United States PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe PD-1/PD-L1 Immunotherapy Market Analysis
-
8.1 Europe PD-1/PD-L1 Immunotherapy Market, by Type
-
8.2 Europe PD-1/PD-L1 Immunotherapy Market, by Application
-
8.3 Europe PD-1/PD-L1 Immunotherapy Market Analysis and Forecast, by Country
-
8.3.1 Germany PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC PD-1/PD-L1 Immunotherapy Market Analysis
-
9.1 APAC PD-1/PD-L1 Immunotherapy Market, by Type
-
9.2 APAC PD-1/PD-L1 Immunotherapy Market, by Application
-
9.3 APAC PD-1/PD-L1 Immunotherapy Market Analysis and Forecast, by Country
-
9.3.1 China PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa PD-1/PD-L1 Immunotherapy Market Analysis
-
10.1 Latin America, Middle East and Africa PD-1/PD-L1 Immunotherapy Market, by Type
-
10.2 Latin America, Middle East and Africa PD-1/PD-L1 Immunotherapy Market, by Application
-
10.3 Latin America, Middle East and Africa PD-1/PD-L1 Immunotherapy Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina PD-1/PD-L1 Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China PD-1/PD-L1 Immunotherapy Company Profiles
-
11.1 Innovent Biologics Inc
-
11.1.1 Innovent Biologics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Innovent Biologics Inc PD-1/PD-L1 Immunotherapy Product Profiles, Application and Specification
-
11.1.3 Innovent Biologics Inc PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 BeiGene Ltd
-
11.2.1 BeiGene Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 BeiGene Ltd PD-1/PD-L1 Immunotherapy Product Profiles, Application and Specification
-
11.2.3 BeiGene Ltd PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Pfizer Inc
-
11.3.1 Pfizer Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Pfizer Inc PD-1/PD-L1 Immunotherapy Product Profiles, Application and Specification
-
11.3.3 Pfizer Inc PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Merck & Co Inc
-
11.4.1 Merck & Co Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Merck & Co Inc PD-1/PD-L1 Immunotherapy Product Profiles, Application and Specification
-
11.4.3 Merck & Co Inc PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Chia Tai Tianqing Pharmaceutical Group Co Ltd
-
11.5.1 Chia Tai Tianqing Pharmaceutical Group Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Chia Tai Tianqing Pharmaceutical Group Co Ltd PD-1/PD-L1 Immunotherapy Product Profiles, Application and Specification
-
11.5.3 Chia Tai Tianqing Pharmaceutical Group Co Ltd PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Novartis AG
-
11.6.1 Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Novartis AG PD-1/PD-L1 Immunotherapy Product Profiles, Application and Specification
-
11.6.3 Novartis AG PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Eli Lilly & Company
-
11.7.1 Eli Lilly & Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Eli Lilly & Company PD-1/PD-L1 Immunotherapy Product Profiles, Application and Specification
-
11.7.3 Eli Lilly & Company PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Sanofi SA
-
11.8.1 Sanofi SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Sanofi SA PD-1/PD-L1 Immunotherapy Product Profiles, Application and Specification
-
11.8.3 Sanofi SA PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 GlaxoSmithKline plc
-
11.9.1 GlaxoSmithKline plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 GlaxoSmithKline plc PD-1/PD-L1 Immunotherapy Product Profiles, Application and Specification
-
11.9.3 GlaxoSmithKline plc PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Bristol-Myers Squibb Company
-
11.10.1 Bristol-Myers Squibb Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Bristol-Myers Squibb Company PD-1/PD-L1 Immunotherapy Product Profiles, Application and Specification
-
11.10.3 Bristol-Myers Squibb Company PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 F Hoffmann-La Roche Ltd
-
11.11.1 F Hoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 F Hoffmann-La Roche Ltd PD-1/PD-L1 Immunotherapy Product Profiles, Application and Specification
-
11.11.3 F Hoffmann-La Roche Ltd PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Regeneron Pharmaceuticals Inc
-
11.12.1 Regeneron Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Regeneron Pharmaceuticals Inc PD-1/PD-L1 Immunotherapy Product Profiles, Application and Specification
-
11.12.3 Regeneron Pharmaceuticals Inc PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 AstraZeneca Plc
-
11.13.1 AstraZeneca Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 AstraZeneca Plc PD-1/PD-L1 Immunotherapy Product Profiles, Application and Specification
-
11.13.3 AstraZeneca Plc PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.14 Jiangsu HengRui Medicine Co Ltd
-
11.14.1 Jiangsu HengRui Medicine Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.14.2 Jiangsu HengRui Medicine Co Ltd PD-1/PD-L1 Immunotherapy Product Profiles, Application and Specification
-
11.14.3 Jiangsu HengRui Medicine Co Ltd PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 PD-1/PD-L1 Immunotherapy Industry Investment Prospect and Risk Assessment
-
12.1 PD-1/PD-L1 Immunotherapy Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 PD-1/PD-L1 Immunotherapy Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure China PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Global PD-1/PD-L1 Immunotherapy Production Value and Growth Rate (2017-2028)
-
Figure China PD-1/PD-L1 Immunotherapy Production Value and Growth Rate (2017-2028)
-
Figure Global PD-1/PD-L1 Immunotherapy Market Size and Growth Rate of PD-1 Inhibitors (2017-2028)
-
Figure Global PD-1/PD-L1 Immunotherapy Market Size and Growth Rate of PD-L1 Inhibitors (2017-2028)
-
Figure Global PD-1/PD-L1 Immunotherapy Market Size and Growth Rate of Non-Small Cell Lung Cancer (2017-2028)
-
Figure Global PD-1/PD-L1 Immunotherapy Market Size and Growth Rate of Esophageal Cancer (2017-2028)
-
Figure Global PD-1/PD-L1 Immunotherapy Market Size and Growth Rate of Urothelial Carcinoma (2017-2028)
-
Figure Global PD-1/PD-L1 Immunotherapy Market Size and Growth Rate of Hepatocellular Carcinoma (2017-2028)
-
Figure Global PD-1/PD-L1 Immunotherapy Market Size and Growth Rate of Small Cell Lung Cancer (2017-2028)
-
Figure Global PD-1/PD-L1 Immunotherapy Market Size and Growth Rate of Others (2017-2028)
-
Figure North America PD-1/PD-L1 Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe PD-1/PD-L1 Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC PD-1/PD-L1 Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa PD-1/PD-L1 Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global PD-1/PD-L1 Immunotherapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China PD-1/PD-L1 Immunotherapy Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China PD-1/PD-L1 Immunotherapy Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China PD-1/PD-L1 Immunotherapy Sales Value, by Manufacturer (2021&2022)
-
Table Global and China PD-1/PD-L1 Immunotherapy Market Share, by Manufacturer (2021&2022)
-
Figure Global and China PD-1/PD-L1 Immunotherapy Market Share, by Manufacturer in 2021
-
Figure Global and China PD-1/PD-L1 Immunotherapy Market Share, by Manufacturer in 2022
-
Table Global PD-1/PD-L1 Immunotherapy Sales Volume, by Type (2017-2028)
-
Table Global PD-1/PD-L1 Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure Global PD-1/PD-L1 Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table Global PD-1/PD-L1 Immunotherapy Sales Value, by Type (2017-2028)
-
Table Global PD-1/PD-L1 Immunotherapy Sales Value Share, by Type (2017-2028)
-
Figure Global PD-1/PD-L1 Immunotherapy Price Trend, by Type (2017-2028)
-
Table China PD-1/PD-L1 Immunotherapy Sales Volume, by Type (2017-2028)
-
Table China PD-1/PD-L1 Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure China PD-1/PD-L1 Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table China PD-1/PD-L1 Immunotherapy Sales Value, by Type (2017-2028)
-
Table China PD-1/PD-L1 Immunotherapy Sales Value Share, by Type (2017-2028)
-
Figure China PD-1/PD-L1 Immunotherapy Price Trend, by Type (2017-2028)
-
Table Global PD-1/PD-L1 Immunotherapy Sales Volume, by Application (2017-2028)
-
Table Global PD-1/PD-L1 Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure Global PD-1/PD-L1 Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Table Global PD-1/PD-L1 Immunotherapy Sales Value, by Application (2017-2028)
-
Table Global PD-1/PD-L1 Immunotherapy Sales Value Share, by Application (2017-2028)
-
Figure Global PD-1/PD-L1 Immunotherapy Sales Value Share, by Application (2017-2028)
-
Table China PD-1/PD-L1 Immunotherapy Sales Volume, by Application (2017-2028)
-
Table China PD-1/PD-L1 Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure China PD-1/PD-L1 Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Table China PD-1/PD-L1 Immunotherapy Sales Value, by Application (2017-2028)
-
Table China PD-1/PD-L1 Immunotherapy Sales Value Share, by Application (2017-2028)
-
Figure China PD-1/PD-L1 Immunotherapy Sales Value Share, by Application (2017-2028)
-
Figure China PD-1/PD-L1 Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Figure North America PD-1/PD-L1 Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Figure Europe PD-1/PD-L1 Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Figure APAC PD-1/PD-L1 Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa PD-1/PD-L1 Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Table North America PD-1/PD-L1 Immunotherapy Sales Volume, by Type (2017-2028)
-
Table North America PD-1/PD-L1 Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure North America PD-1/PD-L1 Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table North America PD-1/PD-L1 Immunotherapy Sales Volume, by Application (2017-2028)
-
Table North America PD-1/PD-L1 Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure North America PD-1/PD-L1 Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure United States PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure United States PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Canada PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Canada PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Mexico PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Table Europe PD-1/PD-L1 Immunotherapy Sales Volume, by Type (2017-2028)
-
Table Europe PD-1/PD-L1 Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure Europe PD-1/PD-L1 Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table Europe PD-1/PD-L1 Immunotherapy Sales Volume, by Application (2017-2028)
-
Table Europe PD-1/PD-L1 Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure Europe PD-1/PD-L1 Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure Germany PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Germany PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure UK PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure UK PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure France PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure France PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Italy PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Italy PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Spain PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Spain PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Belgium PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Poland PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Poland PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Russia PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Russia PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Turkey PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Table APAC PD-1/PD-L1 Immunotherapy Sales Volume, by Type (2017-2028)
-
Table APAC PD-1/PD-L1 Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure APAC PD-1/PD-L1 Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table APAC PD-1/PD-L1 Immunotherapy Sales Volume, by Application (2017-2028)
-
Table APAC PD-1/PD-L1 Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure APAC PD-1/PD-L1 Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure China PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure China PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Japan PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Japan PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure India PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure India PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure South Korea PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa PD-1/PD-L1 Immunotherapy Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa PD-1/PD-L1 Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa PD-1/PD-L1 Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa PD-1/PD-L1 Immunotherapy Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa PD-1/PD-L1 Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa PD-1/PD-L1 Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Brazil PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure South Africa PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Argentina PD-1/PD-L1 Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina PD-1/PD-L1 Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Table Innovent Biologics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Innovent Biologics Inc Product Profiles, Application and Specification
-
Table Innovent Biologics Inc PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table BeiGene Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table BeiGene Ltd Product Profiles, Application and Specification
-
Table BeiGene Ltd PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pfizer Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Inc Product Profiles, Application and Specification
-
Table Pfizer Inc PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Merck & Co Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Merck & Co Inc Product Profiles, Application and Specification
-
Table Merck & Co Inc PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Chia Tai Tianqing Pharmaceutical Group Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Chia Tai Tianqing Pharmaceutical Group Co Ltd Product Profiles, Application and Specification
-
Table Chia Tai Tianqing Pharmaceutical Group Co Ltd PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis AG Product Profiles, Application and Specification
-
Table Novartis AG PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Eli Lilly & Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Eli Lilly & Company Product Profiles, Application and Specification
-
Table Eli Lilly & Company PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi SA Product Profiles, Application and Specification
-
Table Sanofi SA PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table GlaxoSmithKline plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table GlaxoSmithKline plc Product Profiles, Application and Specification
-
Table GlaxoSmithKline plc PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bristol-Myers Squibb Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bristol-Myers Squibb Company Product Profiles, Application and Specification
-
Table Bristol-Myers Squibb Company PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table F Hoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table F Hoffmann-La Roche Ltd Product Profiles, Application and Specification
-
Table F Hoffmann-La Roche Ltd PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Regeneron Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Regeneron Pharmaceuticals Inc Product Profiles, Application and Specification
-
Table Regeneron Pharmaceuticals Inc PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AstraZeneca Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AstraZeneca Plc Product Profiles, Application and Specification
-
Table AstraZeneca Plc PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Jiangsu HengRui Medicine Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Jiangsu HengRui Medicine Co Ltd Product Profiles, Application and Specification
-
Table Jiangsu HengRui Medicine Co Ltd PD-1/PD-L1 Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
